Priewer H, Wolf E, Kraft H, Knauf H, Mutschler E
Department of Biochemistry, University of Frankfurt, GFR.
Pharm Res. 1987 Feb;4(1):66-9. doi: 10.1023/a:1016490113355.
Several derivatives of triamterene were synthesized with the aim of obtaining physicochemical properties superior to those of triamterene. Their effects on electrolyte excretion were tested with dose-response curves in rats: a dissociation of ED50 values of Na+ excretion from those of K+ retention was found; while the ED50 values of natriuresis were structure independent, the ED50 values for potassium retention depended highly on the charge of the side chain of triamterene derivatives. Acidic compounds displayed low and amines high K+-retaining potencies. Hence we postulate that there are at least two sites of action of the tested compounds in the kidney. (i) The first is the Na+ difference; this is the main driving force for K+ secretion. The affinity to the Na+ conductance is not correlated with the basic/acidic properties of the compounds. (ii) The second site is the finite K+ conductance of the luminal membrane of the distal tubule. The affinity of the drugs to this K+ conductance depends strongly on the charge of the molecule. Only pteridine derivatives with a basic side chain, i.e., with a high pKa value, block the membrane K+ conductance and are therefore potent potassium-retaining drugs.
合成了氨苯蝶啶的几种衍生物,目的是获得比氨苯蝶啶更优越的物理化学性质。在大鼠中用剂量-反应曲线测试了它们对电解质排泄的影响:发现钠排泄的半数有效剂量(ED50)值与钾潴留的ED50值解离;虽然利钠作用的ED50值与结构无关,但钾潴留的ED50值高度依赖于氨苯蝶啶衍生物侧链的电荷。酸性化合物显示出低的钾潴留效力,而胺类则具有高的钾潴留效力。因此,我们推测受试化合物在肾脏中至少有两个作用位点。(i)第一个是钠差异;这是钾分泌的主要驱动力。对钠电导的亲和力与化合物的碱性/酸性性质无关。(ii)第二个位点是远端小管腔膜有限的钾电导。药物对这种钾电导的亲和力强烈依赖于分子的电荷。只有具有碱性侧链(即具有高pKa值)的蝶啶衍生物才能阻断膜钾电导,因此是有效的保钾药物。